Literature DB >> 535600

The metabolism and excretion of 7-mono-0-(beta-hydroxyethyl) rutoside in the dog.

A M Hackett, L A Griffiths.   

Abstract

Following i.v. administration of mono-HR to the beagle, plasma levels of both mono-HR and its glucuronide conjugates fell rapidly, neither being detectable 8 h after injection. Following oral administration of 14C-mono-HR, mono-HR-glucuronide was detected in plasma, confirming the absorption of mono-HR, and low levels of 14C were detectable up to 72 h after dosage. Following either oral or i.v. administration of mono-HR, the major route of excretion was fecal elimination of the compound as its aglycone form. Urinary excretion was slight being less than 15% following i.v. dosage and 4% following oral administration. Metabolism of mono-HR was confined to glucuronidation and hydrolytic cleavage of the glycoside side chain. Ring fission products of mono-HR were not detected.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 535600     DOI: 10.1007/BF03189428

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  17 in total

1.  Double-blind study of the efficacy of a soluble rutoside derivative in the treatment of venous disease.

Authors:  H van Cauwenberge
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-04

2.  Metabolism of the hydroxyethylrutosides. Biliary and urinary excretion of 3',4',5-(hydroxyethyl- 14 C), 7-tetra-O-( -hydroxyethyl)-rutoside in rats and monkeys after parenteral administration.

Authors:  A Barrow; L A Griffiths
Journal:  Xenobiotica       Date:  1972-11       Impact factor: 1.908

3.  [Comparative study on the pharmacokinetics of two different preparations of O-(beta-hydroxyethyl)-rutosides in the dog].

Authors:  V Mirkovitch; J W Robinson; F Bel; A Gumma
Journal:  Arzneimittelforschung       Date:  1973-07

4.  The biliary excretion of hydroxyethylrutosides and other flavonoids in the rat.

Authors:  A Barrow; L A Griffiths
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

5.  The effect of O-( -hydroxyethyl)-rutosides (HR) on the peripheral circulation in patients with chronic venous insufficiency.

Authors:  K Roztocil; A Fischer; P Novák; L Rázgová
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

6.  Diabetic retinopathy: study of the action of O-betahydroxyethyl-rutosides (HR) by retinal fluoresceinography.

Authors:  M Tschopp; D Pometta; J Babel
Journal:  Diabetologia       Date:  1970-10       Impact factor: 10.122

7.  Metabolism of the hydroxyethylrutosides. II. Excretion and metabolism of 3',4',7-tri-O-(beta-hydroxyethyl) rutoside and related compounds in laboratory animals after parenteral administration.

Authors:  A Barrow; L A Griffiths
Journal:  Xenobiotica       Date:  1974-01       Impact factor: 1.908

8.  The disposition and metabolism of 3',4',7-tri-O-(beta-hydroxyethyl)rutoside and 7-mono-O-(beta-hydroxyethyl)rutoside in the mouse.

Authors:  A M Hackett; L A Griffiths
Journal:  Xenobiotica       Date:  1977-10       Impact factor: 1.908

9.  Determination of individual hydroxyethyl rutosides in various animal body fluids by thin-layer chromatography and scanning densitometry.

Authors:  A M Hackett; P Niebes; L A Griffiths
Journal:  J Chromatogr       Date:  1978-02-01

10.  The effect of hydroxyethylrutoside (HR) on peripheral blood flow: a preliminary report.

Authors:  D E Fitzgerald; W J Butterfield; J S Keates; M Hodges
Journal:  Bibl Anat       Date:  1969
View more
  1 in total

Review 1.  Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.

Authors:  A N Wadworth; D Faulds
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.